Global InformationTinglong Dai information
 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (August 2022) |
Tinglong Dai | |
|---|---|
 | |
| Nationality | American |
| Academic career | |
| Institution | Johns Hopkins University |
| Field | Operations management Health care analytics Supply chain management |
| Alma mater | Carnegie Mellon University (PhD, 2013) Hong Kong University of Science and Technology (MPhil, 2006) Tongji University (BEng, 2004) |
| Doctoral advisor | Sridhar Tayur Katia Sycara |
| Website | carey |
Tinglong Dai is a Professor of Operations Management and Business Analytics at the Carey Business School, Johns Hopkins University, with expertise in the areas of healthcare analytics, global supply chains, the interfaces between marketing and operations, and human–AI interaction.[1] Dai's research primarily examines the health care ecosystem using analytics approaches, with a focus on behavioral, incentive, and policy issues related to healthcare operations management.[2][3]
In particular, he has worked extensively on the analysis and design of vaccine supply chains, including influenza vaccine contracting,[4] COVID-19 vaccination,[5][6][7][8] and next-generation vaccine manufacturing.[9] He is considered "one of the nation's foremost experts on vaccine distribution."[10]
- ^ "Tinglong Dai, PhD | Johns Hopkins Carey Business School". carey.jhu.edu. Retrieved 2021-09-04.
- ^ "Research & Beyond - Tinglong Dai". Retrieved 2021-09-05.
- ^ "China dominates the pandemic PPE market. What does that mean for U.S. as virus surges?". PBS NewsHour. 2020-10-27. Retrieved 2021-09-05.
- ^ Dai, Tinglong; Cho, Soo-Haeng; Zhang, Fuqiang (2016-03-30). "Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain". Manufacturing & Service Operations Management. 18 (3): 332–346. doi:10.1287/msom.2015.0574. ISSN 1523-4614.
- ^ Mak, Ho‐Yin; Dai, Tinglong; Tang, Christopher S. (2022-10-07). "Managing two‐dose COVID‐19 vaccine rollouts with limited supply: Operations strategies for distributing time‐sensitive resources". Production and Operations Management. 31 (12): 4424–4442. doi:10.1111/poms.13862. ISSN 1059-1478. PMC 9538244. PMID 36246547.
- ^ Dai, Tinglong; Song, Jing-Sheng (2021-09-01). "Transforming COVID-19 vaccines into vaccination". Health Care Management Science. 24 (3): 455–459. doi:10.1007/s10729-021-09563-3. ISSN 1572-9389. PMC 8206869. PMID 34132977.
- ^ Dai, Tinglong; Tang, Christopher (2021-07-21). "How to Build a Coronavirus Vaccine Supply Chain". Bloomberg Law. Retrieved 2021-09-11.
- ^ Dai, Tinglong (2021-02-23). "How to fix the mess of COVID-19 vaccine appointment scheduling". Fast Company. Retrieved 2021-09-11.
- ^ Liljenquist, Dan; Dai, Tinglong; Bai, Ge (2021-02-26). "A Nonprofit Public Utility Approach to Enhance Next-Generation Vaccine Manufacturing Capacity". Population Health Management. 24 (5): 546–547. doi:10.1089/pop.2020.0377. ISSN 1942-7891. PMID 33646049.
- ^ "Q&A with Johns Hopkins University professor, the US top vaccine distribution expert". 25 June 2021. Retrieved 2021-09-05.